scutellarin has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, CY; Luan, Y; Song, JL; Wang, M; Zhang, WB | 1 |
| Feng, S; Liu, X; Lu, Y; Pan, Z; Sun, X; Wang, B; Wang, J; Yang, B; Zhang, X; Zhao, W | 1 |
1 trial(s) available for scutellarin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect of Breviscapine on Recovery of Viable Myocardium and Left Ventricular Remodeling in Chronic Total Occlusion Patients After Revascularization: Rationale and Design for a Randomized Controlled Trial.
Topics: Coronary Occlusion; Double-Blind Method; Flavonoids; Heart; Humans; Myocardial Revascularization; Myocardium; Prospective Studies; Research Design; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2018 |
1 other study(ies) available for scutellarin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.
Topics: Animals; Apigenin; Collagen; Cytokines; Drugs, Chinese Herbal; Echocardiography; Erigeron; Fibrosis; Glucuronates; Heart Failure; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Rats; Rats, Wistar; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |